Atrás
Rango del Día
$63.97
$66.30
Rango de 52 Semanas
$14.80
$69.35
Volumen
1,804,264
Promedio 50D / 200D
$56.68
/
$39.90
Cierre Anterior
$65.08
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -34.1 | 0.4 |
| P/B | 7.3 | 2.9 |
| ROE % | -21.7 | 3.8 |
| Net Margin % | -3985.0 | 3.9 |
| Rev Growth 5Y % | -21.0 | 10.0 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$79.00
+21.6%
Low: $70.00
High: $93.00
EPS Futuro
-$2.42
Ingresos Est.
15 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$6.52
$0.80 – $17.44
|
1.4 B | 3 |
| FY2029 |
$3.22
$0.39 – $8.61
|
910 M | 3 |
| FY2028 |
$0.22
-$1.72 – $3.82
|
460 M | 9 |
Puntos Clave
Revenue declined -20.97% annually over 5 years
Debt/Equity of 0.01 — conservative balance sheet
Negative free cash flow of -132.48M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 275.67%
Capital efficient — spends only 3.32% of revenue on capex
Crecimiento
Revenue Growth (5Y)
-20.97%
Revenue (1Y)254.70%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-21.67%
ROIC-18.84%
Net Margin-3985.02%
Op. Margin-4722.13%
Seguridad
Debt / Equity
0.01
Current Ratio24.63
Interest Coverage0.00
Valoración
P/E Ratio
-34.07
P/B Ratio7.29
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 254.70% | Revenue Growth (3Y) | 345.02% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -20.97% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 4.04M | Net Income (TTM) | -161.00M |
| ROE | -21.67% | ROA | -20.34% |
| Gross Margin | -15.02% | Operating Margin | -4722.13% |
| Net Margin | -3985.02% | Free Cash Flow (TTM) | -132.48M |
| ROIC | -18.84% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 24.63 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -34.07 | P/B Ratio | 7.29 |
| P/S Ratio | 1357.65 | PEG Ratio | -0.42 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 5.48B | Enterprise Value | 5.46B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.04M | 1.14M | 204,000.0 | 191,000.0 | 10.36M |
| Net Income | -161.00M | -88.04M | -48.61M | -35.44M | -12.84M |
| EPS (Diluted) | -2.08 | -1.41 | -1.02 | -0.66 | -0.28 |
| Gross Profit | -607,000.0 | 1.14M | 204,000.0 | 176,000.0 | 10.35M |
| Operating Income | -190.77M | -114.67M | -55.45M | -35.25M | -12.61M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 791.59M | 754.80M | 199.30M | 147.75M | 58.69M |
| Total Liabilities | 38.99M | 21.42M | 14.51M | 22.57M | 18.44M |
| Shareholders' Equity | 752.60M | 733.38M | 184.79M | 125.18M | 40.25M |
| Total Debt | 7.02M | 238,000.0 | 1.03M | 15.94M | 15.13M |
| Cash & Equivalents | 32.49M | 257.07M | 8.27M | 88.14M | 53.61M |
| Current Assets | 759.48M | 754.21M | 194.12M | 147.21M | 58.41M |
| Current Liabilities | 30.84M | 21.37M | 14.25M | 15.43M | 5.98M |